JPWO2022017363A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022017363A5 JPWO2022017363A5 JP2023512465A JP2023512465A JPWO2022017363A5 JP WO2022017363 A5 JPWO2022017363 A5 JP WO2022017363A5 JP 2023512465 A JP2023512465 A JP 2023512465A JP 2023512465 A JP2023512465 A JP 2023512465A JP WO2022017363 A5 JPWO2022017363 A5 JP WO2022017363A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- rpe65
- promoter
- cpg dinucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010704946.1 | 2020-07-21 | ||
| CN202010704946.1A CN113952471A (zh) | 2020-07-21 | 2020-07-21 | 用于治疗眼部疾病的组合物和方法 |
| CN202110378979.6 | 2021-04-08 | ||
| CN202110378979 | 2021-04-08 | ||
| PCT/CN2021/107284 WO2022017363A1 (en) | 2020-07-21 | 2021-07-20 | Compositions and methods for the treatment of ocular diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023535232A JP2023535232A (ja) | 2023-08-16 |
| JPWO2022017363A5 true JPWO2022017363A5 (zh) | 2023-09-25 |
Family
ID=79728991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512465A Pending JP2023535232A (ja) | 2020-07-21 | 2021-07-20 | 眼疾患の処置のための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230321280A1 (zh) |
| EP (1) | EP4185335A1 (zh) |
| JP (1) | JP2023535232A (zh) |
| CN (1) | CN116368228A (zh) |
| AU (1) | AU2021314400A1 (zh) |
| CA (1) | CA3186818A1 (zh) |
| WO (1) | WO2022017363A1 (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023187822A1 (en) * | 2022-03-28 | 2023-10-05 | Indian Institute Of Technology Kanpur | A system for an ocular gene therapy and a process for preparing thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201502137D0 (en) * | 2015-02-09 | 2015-03-25 | Ucl Business Plc | Treatment |
| WO2016193434A1 (en) * | 2015-06-04 | 2016-12-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Improved methods for treating ocular diseases by gene therapy |
| WO2019025984A1 (en) * | 2017-07-31 | 2019-02-07 | Reflection Biotechnologies Limited | CELLULAR MODELS AND THERAPIES FOR OCULAR DISEASES |
| CN111118017B (zh) * | 2018-11-01 | 2023-10-03 | 上海朗昇生物科技有限公司 | 治疗Leber先天性黑蒙症的载体及其应用 |
-
2021
- 2021-07-20 WO PCT/CN2021/107284 patent/WO2022017363A1/en unknown
- 2021-07-20 CN CN202180064406.4A patent/CN116368228A/zh active Pending
- 2021-07-20 EP EP21846029.3A patent/EP4185335A1/en active Pending
- 2021-07-20 CA CA3186818A patent/CA3186818A1/en active Pending
- 2021-07-20 AU AU2021314400A patent/AU2021314400A1/en active Pending
- 2021-07-20 JP JP2023512465A patent/JP2023535232A/ja active Pending
-
2023
- 2023-01-20 US US18/157,577 patent/US20230321280A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20170007720A1 (en) | Methods and compositions for gene delivery to on bipolar cells | |
| AU2018372235A1 (en) | Adeno-associated virus variant capsids and use for inhibiting angiogenesis | |
| US20210395776A1 (en) | Frataxin expression constructs having engineered promoters and methods of use thereof | |
| RU2764920C2 (ru) | Способы и композиции для лечения нарушений и заболеваний, связанных с rdh12 | |
| US11680276B2 (en) | Compositions and methods for treating retinal disorders | |
| US20220290181A1 (en) | Codon optimized rpgrorf15 genes and uses thereof | |
| US20230321280A1 (en) | Compositions and methods for the treatment of ocular diseases | |
| CN114269352A (zh) | 用透明质酸增强aav介导的眼组织转导 | |
| JP2023542279A (ja) | 眼疾患の処置のための組成物および方法 | |
| JPWO2022017363A5 (zh) | ||
| WO2022268110A1 (zh) | 用于治疗b型血友病的组合物和方法 | |
| TWI813851B (zh) | 具有工程化之啟動子之共濟蛋白（ｆｒａｔａｘｉｎ）表現構築體及其使用方法 | |
| US20240067989A1 (en) | Compositions and Methods for Treating Retinal Disorders | |
| JP2024521537A (ja) | 血友病ｂを処置するための組成物および方法 | |
| KR20240073025A (ko) | 간-향성 캡시드 단백질 및 알파-갈락토시다제를 포함하는 aav 입자 및 파브리 질환을 치료하기 위한 이의 용도 | |
| AU2022325158A1 (en) | Aqp1 gene therapy to prevent radiation induced salivary hypofunction | |
| EP4341285A1 (en) | Kcnv2 variants and their use | |
| CN112063625A (zh) | 编码arl2bp的核酸及其应用 | |
| CN117417417A (zh) | 视网膜靶向性的新型腺相关病毒血清型、其制备方法及应用 | |
| CN117904156A (zh) | 人线粒体动力蛋白样gtp酶及应用 | |
| CN111849998A (zh) | 编码人卵黄状黄斑病蛋白1的核酸分子及其应用 | |
| JPWO2022018518A5 (zh) |